Scarica l'app Stockscreener
81.93
1.06%
0.86
Dopo l'orario di chiusura:
81.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$81.07
Aprire:
$81.52
Volume 24 ore:
5.50M
Relative Volume:
0.73
Capitalizzazione di mercato:
$103.91B
Reddito:
$386.46B
Utile/perdita netta:
$4.49B
Rapporto P/E:
22.86
EPS:
3.5841
Flusso di cassa netto:
$4.78B
1 W Prestazione:
-0.71%
1M Prestazione:
+7.27%
6M Prestazione:
+24.29%
1 anno Prestazione:
+45.99%
Intervallo 1D:
$81.08
$82.16
Intervallo di 1 settimana:
$80.51
$83.52
Portata 52W:
$43.56
$83.52
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Confronta CVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
81.93 | 102.82B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
UNH
Unitedhealth Group Inc
|
362.50 | 326.45B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CI
Cigna Group
|
301.78 | 81.43B | 261.22B | 5.40B | 3.94B | 18.31 |
|
ELV
Elevance Health Inc
|
342.35 | 76.96B | 194.82B | 5.53B | 5.34B | 24.45 |
|
HUM
Humana Inc
|
290.65 | 35.04B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Is CVS Health Corporation stock in correction or buying zone2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Using Bollinger Bands to evaluate CVS Health CorporationFed Meeting & Technical Confirmation Alerts - newser.com
UBS Raises Price Target for CVS Health to $96 | CVS Stock News - GuruFocus
CVS Health Corp. Experiences Revision in Score Amidst Market Performance Evaluation - Markets Mojo
Using Python tools to backtest CVS Health Corporation strategiesStop Loss & Capital Efficient Trade Techniques - newser.com
Why CVS Health Corporation (CVS) stock could outperform next yearGap Down & Smart Money Movement Alerts - newser.com
How to build a custom watchlist for CVS Health CorporationProduct Launch & High Return Trade Opportunity Guides - newser.com
CVS Health (CVS) Valuation in Focus Following Medicaid Margin and Contract Loss Concerns - Yahoo Finance
CVS (CVS) Delays Adding Gilead's Yeztugo Over Pricing Concerns - GuruFocus
CVS aims for Q3 momentum amid industry challenges - The Business Journals
CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV drug to get on formularies - statnews.com
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CT company launches new round of layoffs. Here’s how they affect the state. - Hartford Courant
CVS Health’s Quarterly Earnings Preview: What You Need to Know - Barchart.com
CVS Health Corp (NYSE:CVS) Stock Quote - FinancialContent
Why global investors buy CVS Health Corporation stockMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Why CVS Health Corporation (CVS) stock stays on top picksQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
HLTH 2025, Day 3: Health systems weigh AI’s promise against risks - Modern Healthcare
HLTH 2025, Day 4: UPMC eyes AI to boost recruitment - Modern Healthcare
Is CVS Health Corporation Common Stock CVS0 a good long term investmentInsider Buying Signals & Access Our Free Weekly Investment Letter - earlytimes.in
How CVS Health Corporation (Common Stock) (CVS0) stock compares with top peersSell Signal & Real-Time Volume Trigger Notifications - newser.com
CVS says ‘system outage’ impacting some pharmacies - WJBF
CVS says ‘system outage’ resolved, but delays may still occur - KTLA
CVS dealing with ‘known system outage’ impacting pharmacies - ConchoValleyHomepage.com
CVS or HQY: Which Is the Better Value Stock Right Now? - Yahoo Finance
Cvs stock hits 52-week high at 82.88 USD By Investing.com - Investing.com South Africa
Cvs stock hits 52-week high at 82.88 USD - Investing.com
Lobbying Update: $2,150,000 of CVS HEALTH (AND SUBSIDIARIES) lobbying was just disclosed - Quiver Quantitative
Short interest data insights for CVS Health CorporationQuarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
How CVS Health Corporation (CVS) stock reacts to monetary easingWeekly Profit Analysis & Fast Entry Momentum Alerts - newser.com
Will CVS Health Corporation stock deliver stable dividendsCEO Change & Fast Momentum Stock Entry Tips - newser.com
CVS completes conversions of former Rite Aid, Bartell stores - The Business Journals
Measuring CVS Health Corporation’s beta against major indicesJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
CVS Health Corp. Hits New 52-Week High at $79.94 - Markets Mojo
CVS Health Corp. Hits New 52-Week High of $79.67 - Markets Mojo
Earnings Report: Will CVS Health Corporation stock continue dividend increasesWeekly Investment Recap & Real-Time Chart Pattern Alerts - nchmf.gov.vn
Will CVS Health Corporation stock sustain uptrend momentumGold Moves & High Accuracy Swing Trade Signals - nchmf.gov.vn
Will CVS Health Corporation stock outperform tech sector in 2025Earnings Growth Report & AI Driven Stock Price Forecasts - nchmf.gov.vn
CVS Can't Dodge Tobacco Surcharge Suit, Employee Says - Law360
Is CVS Health Corporation (Common Stock) (CVS0) stock undervalued historicallyWeekly Stock Recap & Weekly High Return Stock Opportunities - nchmf.gov.vn
Omnicare pharmacy to close Sacramento facility, laying off 64 employees - The Business Journals
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know - Yahoo
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):